Currently, Aurobindo Pharma, Glenmark and Zydus are in the process of recalling their products in the US market due to manufacturing issues. While the concerns around Aurobindo Pharma and Glenmark Pharma pertain to the "deviation from the current good manufacturing practices (cGMP)", in the case of Zydus, wrong labelling is the reason for recall.
Experts said the recent instances of recall could impact the Indian pharma industry which is already facing the heat globally due to a spate of quality issues over the past two years.
Esta historia es de la edición December 17, 2024 de Financial Express Bengaluru.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición December 17, 2024 de Financial Express Bengaluru.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
IIT-Madras to offer fine arts, culture courses
In a first for Indian Institutes of Technology (IITs), IIT-Madras on Tuesday said it would offer two supernumerary seats in each undergraduate programme to students who have achieved excellence in fine arts and culture, starting from the upcoming academic session.
The world's busiest airline routes in 2024 are largely in Asia
Leisure continues to outshine corporate trips
Not even 2% work-linked higher education courses yet: Report
EDUCATION-INDUSTRY MISMATCH
KYC masking to go live on Jan 20
DEADLINE EXTENDED; BIG RELIEF TO BANKS & FINTECHS
SME IPOs fetch rich returns in Dec
THE SME IPO market continues to see heightened interest and is delivering multibagger returns despite being under the lens of the markets regulator.
Indian firms use euro, yen swaps
MOREOVER, EXPECTATIONS OF dollar strengthening further have also prompted Indian firms to opt for cross-currency pairs other than USD-INR.
EPFO weighs higher equity investments
IN FY23, the interest rate was fixed at 8.15% and 8.10% in FY22.
China plans record budget deficit of 4% of GDP in 2025
New plan compares with an initial target of 3% of 2024 GDP
Trudeau govt adrift after FM quits, Trump tariffs loom
Canada's finance minister leaves the government adrift less than a month before the inauguration of a new US administration that could impose crippling sanctions on Canadian exports.
Markets slump over 1%
ALL MAJOR ASIAN markets ended in the red on Tuesday, a day ahead of the US Federal Reserve's meeting outcome.
